Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study.
Shamshiri H, Fatehi F, Davoudi F, Mir E, Pourmirza B, Abolfazli R, Etemadifar M, Harirchian MH, Gharagozli K, Ayromlou H, Basiri K, Zamani B, Rohani M, Sedighi B, Roudbari A, Delavar Kasmaei H, Nikkhah K, Ranjbar Naeini A, Nafissi S. Shamshiri H, et al. Among authors: gharagozli k. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):506-11. doi: 10.3109/21678421.2015.1074698. Epub 2015 Oct 5. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26437387
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
Pakdaman H, Amini Harandi A, Gharagozli K, Abbasi M, Tabassi A, Ashrafi F, Ghaffarpor M, Sharifi S, Delavar Kasmae H, Assarzadegan F, Arabahmadi M, Behnam B. Pakdaman H, et al. Among authors: gharagozli k. Int J Neurosci. 2017 Jun;127(6):501-507. doi: 10.1080/00207454.2016.1198793. Epub 2016 Jul 19. Int J Neurosci. 2017. PMID: 27279451 Clinical Trial.
Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial.
Pakdaman H, Harandi AA, Hatamian H, Tabatabae M, Delavar Kasmaei H, Ghassemi A, Gharagozli K, Ashrafi F, Emami Naeini P, Tavakolian M, Shahin D. Pakdaman H, et al. Among authors: gharagozli k. Dement Geriatr Cogn Dis Extra. 2015 Mar 7;5(1):96-106. doi: 10.1159/000375295. eCollection 2015 Jan-Apr. Dement Geriatr Cogn Dis Extra. 2015. PMID: 25873931 Free PMC article.
Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran.
Pakdaman H, Amini Harandi A, Abbasi M, Karimi M, Arami MA, Mosavi SA, Haddadian K, Rezaei O, Sadeghi S, Sharifi G, Gharagozli K, Bahrami P, Ashrafi F, Kasmae HD, Ghassemi A, Arabahmadi M, Behnam B. Pakdaman H, et al. Among authors: gharagozli k. Neurol Sci. 2016 Nov;37(11):1773-1778. doi: 10.1007/s10072-016-2661-3. Epub 2016 Jul 11. Neurol Sci. 2016. PMID: 27401807
Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study.
Pakdaman H, Amini Harandi A, Abbasi M, Delavar Kasmaei H, Ashrafi F, Gharagozli K, Assarzadegan F, Behnam B, Arabahmadi M. Pakdaman H, et al. Among authors: gharagozli k. Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):136-142. doi: 10.1159/000458521. eCollection 2017 Jan-Apr. Dement Geriatr Cogn Dis Extra. 2017. PMID: 28626468 Free PMC article.
Epilepsy lifetime prevalence in Iran: a large population- based national survey.
Pakdaman H, Harandi AA, Gharagozli K, Alaeddini F, Esfandani A, Mirbehbahani SH, Doroudi T, Kolivand P, Bahrami P, Kazemi H. Pakdaman H, et al. Among authors: gharagozli k. Sci Rep. 2021 May 3;11(1):9437. doi: 10.1038/s41598-021-89048-z. Sci Rep. 2021. PMID: 33941831 Free PMC article.
46 results